Adhering to current good manufacturing practices (cGMP) is essential to ensuring the safety and effectiveness of medicines. For cell and gene therapy (CGT) manufacturers, cGMP compliance provides the framework to consistently produce high-quality products. Given the intense regulatory scrutiny surrounding CGT approvals, both product quality and manufacturing processes must meet the highest standards. In this infographic, review the most common cGMP hurdles faced in the CGT industry, and the automation and digital solutions that are helping the industry move forward.
Please check the highlighted fields and try again.
Please enter your first and last name.
Please enter the name of the company or institution you work at.
Please enter your mailing address.
By submitting this form, you consent to Cell & Gene Therapy Review storing your email address and contact information and transmitting your contact information to the content sponsor. You may request to be removed at any time.